ABSTRACT Intracellular bacteria use a number of strategies to survive, grow, multiply, and disseminate within the host. One of the most striking adaptations that intracellular pathogens have developed is the ability to utilize host lipids and their metabolism. Bacteria such as Anaplasma, Chlamydia, or Mycobacterium can use host lipids for different purposes, such as a means of entry through lipid rafts, building blocks for bacteria membrane formation, energy sources, camouflage to avoid the fusion of phagosomes and lysosomes, and dissemination. One of the most extreme examples of lipid exploitation is Mycobacterium, which not only utilizes the host lipid as a carbon and energy source but is also able to reprogram the host lipid metabolism. Likewise, Chlamydia spp. have also developed numerous mechanisms to reprogram lipids onto their intracellular inclusions. Finally, while the ability to exploit host lipids is important in intracellular bacteria, it is not an exclusive trait. Extracellular pathogens, including Helicobacter, Mycoplasma, and Borrelia, can recruit and metabolize host lipids that are important for their growth and survival.
INTRODUCTION
"Lipids" is the inclusive name for a complex group of molecules composed predominantly of carbon, hydrogen, and oxygen (also nitrogen and phosphorus) that are insoluble in water but soluble in organic solvents. They are characterized as being hydrophobic or amphiphilic. Lipids include fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycolipids, sterols, polyketides, and prenol lipids. The structures of the lipids discussed in this review are shown in Fig. 1 . The functions of lipids were thought to be limited to being structural components of cell membranes and to being the main form of energy storage in cells. Aside from these important functions, lipids participate in key biological processes that include signaling, organization of the membrane, and trafficking from the membrane to the cytosol. In addition, lipid disorders are key to the pathogenesis of cardiovascular diseases and other metabolic disorders.
Lipids have had a large historical role in infection, first with pore-forming toxins using cholesterol for insertion and with AB toxins that use more complex lipids as their binding receptor. While microbes require lipids either synthesized or acquired for their biological functions, it has become apparent that there is a critical interplay between microbes and cells that require lipids. Specifically, this interplay is most important in the entry process of microbes into the cells and thereafter in the maintenance of their intracellular niches. In the last decade, an increasing number of studies have shown how microbes target and exploit different host lipids involved in a variety of functions. There is a large body of literature documenting the use of lipid microdomains by viruses for entry into the cells (see references 1 and 2 for reviews on this topic). Entry mechanisms using cell membrane lipids are also increasingly documented for bacteria, fungi, and protozoa. Following entry, lipids continue to be essential for the completion of the intracellular life cycle of the microbes. Incorporation of lipids within a cell environment can protect microorganisms from the effects of an acidified phagolysosomal compartment. Some pathogens can avoid the deleterious acidification of the phagolysosome through recruitment of host cell lipids, allowing the organisms to use a hostile environment and convert it into one where they can multiply and grow.
As mentioned earlier, the use of lipid molecules on the membranes of cells by a large variety of both DNA and RNA viruses has been amply documented. Likewise, the field of bacterial toxins utilizing lipid microdomains as binding sites in target cells has been reviewed exhaustively (3) . Thus, the aim of this review is to summarize in a comprehensive manner the different strategies that bacteria use to exploit host lipids and hijack the cellular machinery to infect, survive, multiply, and disseminate in the host. In addition, we will review the importance of host lipid acquisition by extracellular pathogens. Even after narrowing down the scope of this chapter, we have found that the topic that we have chosen has been the subject of several excellent reviews that we have used as models for our own (4) (5) (6) (7) (8) (9) . Some bacteria recruit cholesterol, sphingolipids, and phospholipids directly from the host. Although the list of prokaryotes that incorporate cholesterol and sphingolipids is growing, bacteria in general do not have the cellular tools to synthesize these lipids, but many have evolved the enzymatic machinery required to modify them. Prokaryotes incorporate host lipids for different reasons, and these can include cell permeability, membrane fluidity, energy or nutrient sources, and signaling processes. Bacteria can also modify and rearrange their lipid composition in the membrane in response to different conditions such as stress, temperature changes, or other types of stimuli.
In this chapter, we will review lipid incorporation by bacteria that are extracellular and bacteria that are either facultative or obligate intracellular organisms. The use of lipids is different between the two groups. For example, intracellular bacteria use host lipids to avoid phagosome maturation and to multiply in the intracellular niche, whereas extracellular bacteria incorporate lipids in their membrane, where they play a structural role. Nonetheless, lipids, particularly cholesterol, are increasingly recognized in bacteria (Table 1) , and their lipidome is of both biological and pathogenesis interest.
Mass spectrometry techniques have been developed and applied to study the lipidome of bacteria and to evaluate their changes under different conditions (10) (11) (12) . This is of special importance for pathogens of the genus Mycobacterium that contain 60% of cellular dry weight corresponding to lipids and can change their membrane lipid profile in response to stress condition such as pH (10) . Lipids contribute to the impermeability of the cell wall, increasing the virulence of the Mycobacterium tuberculosis organism. Likewise, Borrelia burgdorferi, the agent of Lyme disease, and Helicobacter pylori, the causative agent of gastritis and peptic ulcer disease, incorporate cholesterol and modify it into glycolipids. Specifically, B. burgdorferi assembles the cholesterol and cholesterol glycolipids into lipid microdomains that resemble eukaryotic lipid rafts.
Cholesterol is an essential structural component of the cell membrane of vertebrates, and it is required for membrane integrity and fluidity. In eukaryotic cells, cholesterol and sphingolipids are the main components of membrane microdomains known as lipid rafts (13-15; for review see reference 16) . These microdomains are characterized by being more tightly packed than the surrounding bilayer and enriched with proteins involved in signaling and other fundamental biological processes (17) , including receptor clustering and lateral sorting of proteins, such as glycosylphosphatidylinositol (GPI)-anchored proteins and lipoproteins (18, 19) , endocytosis, exocytosis, vesicle formation, and budding (20) (21) (22) . Part of this review will focus on the use of eukaryotic lipid rafts by bacteria. This is a rapidly growing area of bacterial pathogenesis that affects entry as well as downstream events after the bacteria are internalized. Use of lipid rafts as points of attachment and entry of bacteria is shared by both Gram-positive and Gramnegative organisms and also by extra-and intracellular species. The importance of this association is evidenced by earlier reviews of the topic (23, 24) .
The use of lipid receptors for bacterial toxins has been established for years. In this review, we have not included toxin use for adhering to lipid domains on the surface of the target cells because a significant literature on this topic exists. Instead, our focus is on the use of lipid rafts as entry points into cells. There is significant information that distills a common theme that at least some bacteria show a marked preference for attaching to lipid microdomains to initiate entry into the cells. Not all the literature is in agreement, however, because some of the procedures that are used to remove cholesterol, and therefore show inhibition of entry, can create a number of unforeseen effects that could complicate the interpretation of results.
Infection of eukaryotic cells with bacterial pathogens includes the adhesion of the pathogen to surface lipid receptors (lipid rafts) of the cell. The attachment process can continue with the recruitment of proteins to the entry site, which in turn can assist in the remodeling of the membrane and the development of signal transduction required for internalization of the pathogen (such as actin polymerization). Once internalized, the bacteria in the phagosome will need to recruit lipids that are necessary for their nutrition and in some instances to avoid phagosome fusion with lysosomes to escape the degradation of the pathogen. In this review, we will present evidence for all parts and stages of this process. Splitting the process into entry, membrane reorganization, and acquisition of lipids is somewhat arbitrary because the entire process is a continuum. However, for the purposes of this review each will be considered separately.
BACTERIAL USE OF HOST LIPIDS FOR ENTRY INTO CELLS
A number of bacterial organisms have an obligate intracellular existence, notably, the chlamydiae and the rickettsiae. The others are facultative intracellular bacteria. Obviously, adaptations for entry by obligate organisms are critical for their survival, and these adaptations represent the strong association between the parasitic prokaryote and its eukaryotic cell host. The Chlamydiaceae are obligate intracellular bacteria, and significant research has been conducted regarding the use of lipids for cell entry by species of this genus. Chlamydia trachomatis is the most commonly reported sexually transmitted agent and also the most common of all notifiable infections (25, 26) . C. trachomatis infects the lower genital tract of men as an agent of urethritis, prostatitis, and epididymitis (27) (28) (29) and cervicitis, salpingitis, and pelvic inflammatory disease in women (30) (31) (32) . This species is also a major cause of trachoma and conjunctivitis in developing countries (33, 34) . There is an enlarging clinical spectrum for C. trachomatis such as being a cofactor for HIV infection (35) . Chlamydophila (Chlamydia) pneumoniae is responsible for outbreaks of community-acquired pneumonia, pharyngitis, and bronchitis (36) . In addition, C. pneumonia has been reported to be involved in the development of atherosclerosis (37) (38) (39) . Collectively, these diseases are a major global public health problem. The chlamydiae have a unique dimorphic life cycle. The elementary body is the infecting stage and infects preferentially mucosal epithelial cells. The reticulate body is the dividing stage within large phagosomes known as inclusions (40) . There are some important aspects that have been worked out for the entry of these bacteria into cells. These organisms promote the reorganization of actin, and early tyrosine phosphorylation is common across Chlamydia species and is associated with entry. Chlamydia secretes proteins into the host cell through a type III secretion system (TTSS) that can contribute to their internalization. One such translocated protein is Tarp (translocated actin-recruiting phosphoprotein), and it is phosphorylated with a critical role in the actin-driven uptake of the bacteria (41) . Small GTPases of the Rho (42, 43) and ARF family (44) have also been shown to be important in actin-dependent internalization.
The infection starts with the internalization of the elementary bodies, and it involves interactions between chlamydial ligands and receptors on the surface of the cell. Proteoglycans have been possible candidates for initial contact of the elementary bodies with the cell surface, and this association may be a charge-driven interaction. A number of studies of Chlamydia point to lipid rafts as the site of entry in the cell and for subsequent internalization of the elementary bodies (42, 45, 46) . Experiments using methyl-β-cyclodextrin (45) (46) (47) as an agent for cholesterol depletion or other cholesterol sequestering reagents (45, 48, 49) have shown that elementary bodies attach to cells at sites of high cholesterol concentration. Some studies have shown that Chlamydia enters the cell through membrane areas rich in GM1, a lipid raft marker (42) , and colocalizes with caveolin-1 and caveolin-2 (48, 50). C. pneumoniae, an agent of respiratory infections in humans, and Chlamydia psittaci, a pathogen of birds that can also infect humans, each enter host cells after attachment to lipid rafts rich in cholesterol. Attachment to lipid rafts is not universal, however. While C. trachomatis serovars E and F also use lipid rafts to enter host cells, lipid rafts with associated caveolin were not used for entry of C. trachomatis serovars A-C (49).
Signaling molecules that are involved in bacterial entry into cells also partition in lipid rafts (51) (52) (53) . It appears that Cdc42 and Rac (both small GTPases of the Rho family involved in morphological changes, migration, and actin polymerization) are translocated to lipid rafts in response to lipopolysaccharide (52) , and these are also important in the entry of the elementary bodies. C. trachomatis has a number of serovars that behave differently on entry of the cells, and this emphasizes the individuality of these variants. Serovars A and C (associated with trachoma) are not inhibited by the removal of cholesterol; rather, they enter the cells through clathrin-mediated endocytosis (49) . Likewise, the approaches of entry for serovars E and K remain unclear since different research groups reached different conclusions (47, 49) . These biological distinctions between chlamydial species as well as between C. trachomatis serovars are reflected in the interaction with host cells and the route of entry and could be due to the localization of the cell surface molecules used by different species/serovars to enter cells.
Brucella spp. are Gram-negative, facultative intracellular bacteria of medical and veterinary importance. These organisms replicate within a phagosome inside phagocytic cells as well as other cells. Inhibition of phagosome fusion with the lysosome appears to promote intracellular survival. Lipid raft disruption by filipin, methyl-β-cyclodextrin, and cholera toxin interfered with the entry process. Thus, lipid rafts may provide a portal of entry for Brucella into murine macrophages under nonopsonic conditions, thus allowing phagosome-lysosome fusion inhibition, which in turn promotes intracellular survival (54) . Several approaches were used to show that plasma membrane cholesterol of macrophages is required for the VirB-dependent internalization of B. abortus and also contributed to the establishment of bacterial infection in mice after entry (55) . The entry of B. abortus into macrophages was found to be more complex through the use of the class A scavenger receptor in addition to the requirement for location of this receptor within lipid rafts (56) . The entry of Brucella ovis and Brucella canis into macrophages was mediated by a class A scavenger receptor, cholesterol, and ganglioside GM1 (57) . The entry of Brucella spp. through membrane microdomains that contain cholesterol requires other protein receptors that have to be associated with the lipid structures. The association of proteins with lipid microdomains as portals of entry into cells is frequent among facultative intracellular bacteria.
Bordetella bronchiseptica, which is closely related to the agent of pertussis is an important veterinary pathogen, adhered to host cells at GM1-enriched lipid raft microdomains. BteA, a cytotoxic effector protein delivered by the TTSS of this bacterium, colocalized to lipid rafts as well, and disruption of the lipid rafts reduced its cytotoxicity. This study is significant in that it identified a 130-amino acid lipid raft targeting domain at the N-terminus of BteA (58) .
Francisella tularensis is a Gram-negative facultative, intracellular zoonotic pathogen capable of infecting many different living organisms from protozoa to humans. F. tularensis was found to attach to cholesterolrich lipid rafts in association with caveolin 1 for entry into mouse macrophages. Treatment of the mouse macrophages with cholera toxin and with phosphatidylinositol phospholipase C to inhibit attachment or destabilize the lipid rafts by removal of GPI-anchored proteins inhibited entry of F. tularensis and thereafter inhibited its intracellular proliferation (59) .
Gram-negative enteric species (Salmonella, Shigella) use lipid microdomains rich in cholesterol for attachment to and entry into cells of the alimentary canal. A molecular complex involving proteins of both the host, CD44, the hyaluronan receptor, and Shigella, the invasin IpaB, is enriched in lipid rafts containing cholesterol and sphingolipids. This study also demonstrated the accumulation of cholesterol and raft-associated proteins at the Shigella entry site, and depletion of cholesterol and sphingolipids resulted in decreased invasion (60) . Using cells that are deficient in the formation of lipid rafts, a recent study showed that cholesterol is not essential for invasion and intracellular replication by Salmonella enterica serovar Typhimurium and C. trachomatis, but entry of Coxiella burnetii into the host cell was impaired, indicating that cholesterol is important for this species (61) .
Although not an intracellular enteric bacterium, H. pylori has effector molecules that use lipid microdomains for attachment. The vacuolating toxin (VacA) of H. pylori intoxicates cells. Treatment of target cells with cholesterol-depleting agents interfered with the internalization or intracellular localization of VacA and reduced vacuolation. The study concluded that VacA associates with lipid rafts for entry into the cells and is important for downstream cytotoxicity (62) . Another effector from H. pylori requires lipid rafts for attachment. Delivery of CagA into epithelial cells by the bacterial type IV secretion system (T4SS) is mediated in a cholesterol-dependent manner (63) . The α(5)β(1) integrin is found in lipid rafts and is a known ligand for attachment and translocation of CagA leading to cytoskeletal rearrangements. Integrin α(5)β(1) and the cholesterol-rich microdomains at the host cell surface are required for NOD1 recognition of peptidoglycan and subsequent induction of NF-κB-dependent responses to H. pylori. These results demonstrated that lipid rafts are a novel platform for delivery of bacterial effectors (CagA) to target the cells (64) .
Infection with Pseudomonas aeruginosa, a Gramnegative bacterium, targets the respiratory system of susceptible individuals. Essentially opportunistic, P. aeruginosa is a dangerous bacterium that causes serious complications in patients with cystic fibrosis and neutropenia. In addition, P. aeruginosa infects the eyes and the skin in burn patients. It is unclear whether infection of macrophages with this bacterium prolongs or shortens the infection. However, understanding the molecular mechanisms of ingestion by these cells has provided important clues about its pathogenesis. Recently, lipid rafts that contain sphingolipids and cholesterol have been shown to be important for the initial interaction of the bacterium with the cell membrane. A number of studies have documented the predilection for the lipid microdomains for binding of P. aeruginosa.
On contact with cells, P. aeruginosa increased the enzymatic activity of the acid sphingomyelinase of macrophages, and this resulted in the release of ceramide into sphingolipid-rich rafts. The increase of ceramide led to the reorganization of the rafts into larger signaling platforms that are required to internalize P. aeruginosa. Once inside, the bacterium can induce apoptosis and regulate the cytokine response, which are both necessary to initiate the innate immune response. Failure to generate ceramide-enriched membrane platforms leads to a dysfunctional inflammatory response with resulting cytokine release and irreversible sepsis of mice. This study demonstrated that reorganization of the lipid rafts by incorporation of ceramide is essential for the initiation of cell defenses against this organism (65) .
P. aeruginosa is a frequent cause of eye infections, particularly after corneal injury through the use of contact lenses. Lipid raft formation was evaluated in vivo in rabbit corneas with and without contact lens use. In addition, a human corneal epithelial cell line was used to detect lipid raft formation following infection with P. aeruginosa. Contact lens use in rabbits resulted in lipid raft formation. Likewise, the bacteria displayed preferential attachment to lipid rafts and to lipid raft aggregation, which in turn facilitated internalization by the cells (66). P. aeruginosa enters corneal epithelial cells in vitro via membrane microdomains or lipid rafts. In addition to lipid microdomains, P. aeruginosa has utilized the cystic fibrosis transmembrane conductance ASMscience.org/MicrobiolSpectrumregulator (CFTR) for bacterial entry. A study to determine colocalization of the CFTR with or within lipid rafts was conducted using corneal cells expressing wildtype or Δ CFTR infected with this organism. P. aeruginosa and CFTR colocalized with the lipid rafts, leading to the conclusion that this bacterium enters human corneal epithelial cells via lipid rafts containing CFTR (67) . Another study focused on the utilization of lipid rafts and specific proteins to facilitate the entry of P. aeruginosa into alveolar macrophages. Lyn, a member of the Src family tyrosine kinases, is mainly a negative regulator in B lymphocytes and is instrumental in ingestion. It appears that phagocytosis is initiated by lipid rafts and is dependent on Lyn. Blocking of Lyn and effectors of cholesterol synthesis inhibited ingestion of P. aeruginosa by alveolar macrophages. Moreover, both Lyn and lipid rafts followed the bacterium inside the cell, where they exerted various host defense functions (68) .
P. aeruginosa uses a novel approach to deliver virulence factors without actually attaching to the cell. This organism uses outer membrane vesicles for the longdistance delivery of bacterial effectors into the host cell cytoplasm. The outer membrane vesicles deliver their protein cargo by fusing with lipid rafts in the host plasma membrane. This fusion process has also been used by B. burgdorferi, and it is essentially based on a lipid-lipid interaction. The P. aeruginosa virulence factors enter the host cell via Neural Wiskott-Aldrich syndrome protein (N-WASP)-mediated actin trafficking and thereafter migrate to other locations within the cell where they can affect the biology of the cell. The outer membrane vesicle route provides for a coordinated delivery system of bacterial effectors. The lipid rafts of the cell constitute the fusion platform to initiate the infection (69) .There are other organisms that have been reported to use lipid microdomains for entry or attachment to cells, and these are summarized in Table 2 .
BACTERIAL USE OF HOST LIPIDS FOR INTRACELLULAR GROWTH
The studies of acquisition of host lipids into phagosomes to maintain the growth and viability of intracellular bacteria represent major advances in both cell biology and microbiology. However, these studies are uneven in their representation of the various intracellular bacterial species. A large amount of work has been done on the acquisition and transport of lipids by the Chlamydiae, and its review summarizes a great chapter in bacterial pathogenesis.
After entry, the elementary bodies are bound into the inclusion which is derived from the host plasma membrane. The elementary bodies differentiate into reticulate bodies and begin to replicate. The inclusion avoids fusion with lysosomes and is transported to the Golgi region. During this period of chlamydial growth and replication, the inclusion is an active partner, and it interacts with different cellular compartments and trafficking pathways to acquire nutrients.
Chlamydia requires lipids from the host cell for survival and has developed different mechanisms to recruit sphingolipids and cholesterol from within the inclusion. The Golgi apparatus provides the main network for vesicular transport of lipids in host cells. Nonvesicular transport of lipids is modulated by cytosolic lipid transfer proteins. Chlamydia has developed diverse strategies to use vesicular and nonvesicular pathways for the acquisition of lipids. The Chlamydiae bacteria have the biochemical machinery to synthesize phosphatididylethanolamine, phosphatidylglycerol and phosphatidylserine (70, 71) . Nonetheless, the membranes of C. trachomatis have substantial amounts of lipids derived from the host cells, notably sphingomyelin and cholesterol (70) (71) (72) . Since this organism does not have the ability to synthesize these lipids, it must obtain them from the host (73) . Specifically, the Chlamydia require sphingomyelin (74, 75) . Lipid recruitment may be mediated by host proteins in the membrane of the inclusion. Although it has not been defined yet how the host proteins are associated with the inclusion membrane, it has been proposed that some inclusion proteins could be responsible for the binding (76) . Inclusion proteins are abundant in the membrane of the inclusion (i.e., phagosome), and over 50 such proteins have been characterized (77); a secondary structure characteristic in the form of bilobed hydrophobic domains has been found to target inclusion proteins to the inclusion membrane (78) .
Ceramide, the precursor of sphingomyelin and cholesterol, is acquired through Golgi-dependent processes, and a number of studies indicate that these processes are used effectively by the Chlamydia to locate these lipids in the inclusion membrane (72, (79) (80) (81) (82) . This is possible because there is a close association between the inclusion and the Golgi complex where sphingomyelin is synthesized. Ceramide is converted to sphingomyelin in the Golgi and subsequently accumulates within the inclusion membrane as early as 2 h postinfection (79, 80) . To accomplish this, C. trachomatis intercepts an exocytic pathway by fusing vesicles containing sphingomyelin exiting the trans-Golgi in transit to the plasma membrane, and this is a common feature of several Chlamydia species (83, 84) . Treatment of infected cells with a pharmacological inhibitor of the assembly of multivesicular bodies delayed the development of the inclusion and inhibited the acquisition of sphingomyelin and cholesterol (85) . However, Golgi-dependent pathways appear to be specific to only certain lipids, because other lipids are not intercepted (86) .
Chlamydia can utilize the ceramide-transfer protein (CERT) to promote the trafficking of ceramide from the endoplasmic reticulum to the inclusion membrane for subsequent conversion to sphingomyelin (82, 87) . Subsequent studies showed that IncD (an inclusion membrane protein) can mediate the recruitment of CERT (88) . It appears that the CERT-IncD interaction is very important and specific, because a nonhuman strain that infects guinea pigs, Chlamydia caviae, lacks IncD and does not recruit CERT to the inclusion membrane (87) . However, as mentioned earlier, there are many pathways that the Chlamydiae use to incorporate lipids onto the inclusion membranes. Although the CERT pathway is important and specific, C. caviae can still incorporate sphingomyelin despite its lack of utilization of the CERT-IncD pathway (83) .
Inhibition of CERT activity resulted in a decrease in the acquisition of sphingomyelin onto the inclusion membrane (82) . This intriguing observation suggests that CERT binds ceramide at the endoplasmic reticulum to the inclusion, where it assembled into sphingomyelin. Alternatively, CERT can transfer ceramide to the Golgi, where it is converted to sphingomyelin and subsequently transferred to the nearby inclusion by vesicular traffic (82) .
Dysfunction of organelles also enhances lipid uptake by the Chlamydia within the inclusion. Sphingomyelin incorporation into the inclusion increased as a result of Golgi fragmentation. The Golgi is fragmented into mini-stacks that surround the inclusion, leading to enhancement of C. trachomatis replication. Mini-stack formation is mediated by host, Golgin-84, and chlamydia, chlamydial protease like activity factor (CPFA), proteases (89) . This is a unique means of lipid acquisition, where the bacteria and the host cell have a role in the degradation of the organelle (90, 91 ).
An increasing number of studies are linking specific proteins for translocation to the inclusion membranes, where they could play important roles in lipid acquisition, and some of these proteins can bind lipids directly. Chlamydia can acquire sphingomyelin by co-opting a subset of Golgi trafficking proteins including Arf1 GTPase (92) and GBF1 (82), a regulator of Arf1-dependent vesicular trafficking, and both are essential for inclusion membrane growth and stability. A small interfering RNA screen identified Src family kinases in the acquisition of sphingomyelin (93) . The possibility of lipid acquisition pathways involving Incs and Rab GTPases has been explored, indicating that the latter are recruited to the inclusion membrane (94, 95) . RabGTPases 6, 11, and 14 are key regulators of the Golgi apparatus; Chlamydia subverts the Golgi structure to enhance its intracellular development, presumably by mobilizing the Golgi fragments (91, 96) . SNARE proteins can be instrumental in the fusion with host vesicles for acquisition of lipids (97) .
Chlamydia acquires cholesterol from a low-density lipoprotein (LDL) pathway and from de novo synthesis (72) . Lipid droplets have also been implicated as a source of neutral lipids. Lipid droplets are most obvious at the periphery of the inclusion and are translocated into the phagosome at IncA-rich sites (98, 99) .
Anaplasma phagocytophilum is a Gram-negative, tick-borne bacterium that contains cholesterol in its outer membrane but does not produce lipid A. This bacterium occupies a unique niche within neutrophils and is an obligate intracellular microbe. A. phagocytophilum cannot synthesize cholesterol, so it has to acquire cholesterol directly from its host cells or from the medium (100). Cholesterol is required for growth of A. phagocytophilum in HL-60 cells, the preferred laboratory cell for cultivation of this organism. Even more important, high serum levels of cholesterol enhance A. phagocytophilum infection in the mouse model (101) . This obligate intracellular bacterium uses cholesterol not only for growth and survival, but also uses it to enter host cells through caveolae or lipid rafts. The phagosome membrane maintains caveolin-1 throughout infection, indicating that there is a need for continuing acquisition of cholesterol (102) . The manner by which A. phagocytophilum acquires cholesterol involves the use of the host cell pathway for uptake of this lipid. The source of cholesterol required for A. phagocytophilum replication is derived from serum LDL rather than from cholesterol synthesized by the cells themselves. A. phagocytophilum uses the host LDL uptake pathway and the LDL receptor mRNA regulatory system to acquire cholesterol in the phagosome to enhance its growth. Anaplasma acquires host cholesterol derived exclusively from serum LDLs, because infection with this bacterium can be blocked using pharmacological inhibitors of the LDL-CHOL vesicular transport pathway. These results demonstrate a unique evolutionary adaptation of A. phagocytophilum for the acquisition of cholesterol by upregulating low-density receptors. These findings also illustrate how A. phagocytophilum hijacks host cell cholesterol pathways for its own benefit (103).
C. burnetii is an obligate intracellular Gram-negative bacterial pathogen and the causative agent of Q fever. The genus Coxiella is closest to the Legionella but has several important differences. One important difference is that C. burnetii helps in the development of a parasitophorous vacuole that is required for replication. Intracellular vacuolar pathogens such as C. burnetii require lipids for both normal bacterial functions as well as formation of the acidic vacuole surrounding the bacteria. Host-derived cholesterol is necessary for the creation and maintenance of the vacuole, and its incorporation has been established by positive staining with filipin for the lipid raft marker, flotillin, showing that the vacuolar membranes are enriched in cholesterol and contain lipid raft microdomains (104) . Inhibition experiments using pharmacological agents that inhibit uptake of cholesterol altered the morphology of the vacuoles and partially inhibited C. burnetii replication. The formation of vacuoles was inhibited after treatment of cells with inhibitors of cholesterol uptake and synthesis. This study concluded that C. burnetii interferes with cholesterol metabolism and that cholesterol is required for intracellular replication (104) . Using Chinese hamster ovary cells as a model, it was shown that the vacuoles of these cells infected with C. burnetii are rich in cholesterol, which is essential for growth of this organism in these cells (105) . Unlike other organisms that incorporate lipids, C. burnetii can acquire lipids through both synthesis and utilization of host cell pools. The C. burnetii genome encodes enzymes for the synthesis of fatty acids and phospholipids, but C. burnetii also requires sterols for the biogenesis of the vacuoles. C. burnetii lacks enzymes for de novo cholesterol biosynthesis, but it encodes a sterol reductase homolog. This enzyme occurs infrequently in prokaryotes, and it reduces sterol double bonds in the final step of cholesterol biosynthesis. Working with the Coxiella gene in a yeast system, it was demonstrated that the sterol reductase of this organism was active and was likely to act on host sterols during C. burnetii intracellular growth (106) .
This bacterium lacks the synthetic machinery to generate cholesterol. Yet it is known that C. burnetii utilizes host cell lipids for creation of the vacuole, implying that it can manipulate the cell's lipid-signaling pathways to support the intracellular location, for example, effectors secreted by C. burnetii. The T4SS of this organism may be involved in the utilization of cell lipids. A recent review considers all aspects of lipid utilization by this species (107) . A new model system was used to assess cholesterol requirements in infection of mouse embryonic fibroblasts with C. burnetii, S. Typhimurium, and C. trachomatis. A cell line deficient in sterol reductase, and hence unable to complete cholesterol biosynthesis, was used to determine the role of cholesterol in infection with the three pathogens. Infection of the sterol reductase-deficient cells by S. Typhimurium and C. trachomatis was unaltered, whereas C. burnetii entry was significantly decreased, suggesting a role for lipid rafts in the ingestion of this bacterium. All three pathogens established residence in their respective vacuoles and replicated normally in the sterol reductase-deficient fibroblasts, except that the C. burnetii vacuoles were abnormal. While this study argued that cholesterol is not essential for invasion and replication by S. Typhimurium and C. trachomatis, it appears to be critical for invasion and growth of Coxiella (61).
Studies with F. tularensis also showed that cholesterol and caveolin-1 were incorporated into Francisellacontaining vesicles during entry and the initial phase of intracellular trafficking inside the host cell (59). F. tularensis also can invade nonphagocytic cells, notably hepatocytes (108) . Francisella novicida uses clathrinand cholesterol-dependent mechanisms to invade hepatocytes. Clathrin accessory proteins AP-2 and Eps15, but not caveolin, colocalized with invading F. novicida.
Caveolin was thus not required for the organism to enter hepatocytes. These results demonstrate that members of the same genus can utilize diverse entry pathways (109).
A ubiquitous early step in infection of humans and animals by enteric bacterial pathogens such as Salmonella spp., Shigella spp., and enteropathogenic Escherichia coli (EPEC) is the translocation of virulence effector proteins into mammalian cells via specialized TTSSs. Translocated effectors subvert the host cytoskeleton and stimulate signaling to promote bacterial internalization or survival. Target cell plasma membrane cholesterol is central to pathogen-host cross-talk, but the precise nature of its critical contribution remains unknown.
The uptake of Listeria monocytogenes, the Grampositive agent of listeriosis, by nonphagocytic cells is accomplished by an assembled complex involving the bacterial proteins internalin and InlB and their host cell receptors E-cadherin and hepatocyte growth factor receptor (HGF-R)/Met, respectively. Through the use of lipid raft markers such as acyl-modified and GPIanchored proteins, GM1 ganglioside, as well as cholesterol depletion, it was found that the presence of E-cadherin in lipid domains was necessary for initial interaction with internalin to promote bacterial entry. However, the initial interaction of InlB with HGF-R did not require membrane cholesterol. Downstream events after entry required cholesterol for F-actin polymerization (110) . Listeriolysin O, a pore-forming toxin of L. monocytogenes, intercalates into cholesterol-rich membranes of target cells. However, this toxin also assists in the clustering of the lipid rafts. Evidence provided by the clustering of GPI-anchored proteins in membranes after listeriolysin treatment strengthened its role in the clustering of lipid rafts (111) .
Enterohemorrhagic E. coli (EHEC) O157:H7 and EPEC O127:H6 can bind to intestinal epithelium at attaching-effacing lesions that undergo cytoskeletal rearrangements and loss of microvilli. The cholesterol requirement was documented for EPEC (112) , and E. coli (type 1 fimbriated) invades uroepithelial cells via lipid rafts (113) . Cholesterol depletion of epithelial and fibroblast cells resulted in inhibition of cytoskeletal rearrangement after exposure to both EHEC and EPEC, an effect that was restored by the addition of exogenous cholesterol. There were some differences in attachment by the two types of E. coli. Adherence to epithelial cells was reduced following cholesterol depletion in EPEC, but not in EHEC, bacteria (114) . Likewise, extracting or changing membrane-bound cholesterol with methyl-β-cyclodextrin or filipin inhibited the entry of Dr-positive IH11128 E. coli into epithelial cells (115) .
S. Typhimurium inhibits phagolysosome fusion and survives in a late endosome-like vacuole. Salmonella infection induces cholesterol accumulation in the vacuoles of both macrophages and epithelial cells and is dependent on intracellular replication. GPI-anchored protein CD55 is also recruited to the vacuole, suggesting an important role for cholesterol use (116) . Enteroinvasive Shigella also uses a molecular complex involving proteins from the host, CD44, the hyaluronan receptor, and the bacterial invasin IpaB, that partition in lipid rafts. Cholesterol accumulated at the entry site of the Shigella organism and its depletion resulted in decreased invasion of the cells. In addition, cells that are deficient in sphingolipids had decreased invasion by the bacteria. These results pointed to a role for lipid microdomains in shigellosis (60) . Shiga-toxigenic E. coli O113:H21 require lipid rafts to invade colonic epithelium (117) .
Using in vitro cholesterol-binding assays provided a demonstration that two TTSS translocon molecules from Salmonella (SipB) and Shigella (IpaB) bound cholesterol with high affinity. Cholesterol depletion reduced the translocation of these molecules into cells, demonstrating a cholesterol-dependent association of the bacterial TTSS translocon with lipid rafts in the cell membrane (118) . The presence of cholesterol on the host cell surface was essential for contact-mediated activation and TTSS-induced hemolysis. Purified detergentresistant membranes and liposomes with a composition similar to lipid rafts activated the TTSS (119) .
Mycobacteria are facultative intracellular pathogens that can survive inside macrophages. Cholesterol is essential for uptake of Mycobacteria by these cells by accumulation at the site of entry. Furthermore, once ingested, cholesterol mediates phagosome survival (120) . When given a cholesterol-rich diet, tubercular patients cleared the bacilli from the sputum significantly faster (121) . Mycobacterium avium induced lipid raft formation in mouse-derived macrophage cell lines, and the internalized organisms required cell-membrane-derived cholesterol. Follow-up experiments showed that mycobacterial lipids of high polarity interact with lipid rafts from the host cell (122) . M. tuberculosis can use cholesterol as a sole carbon source. The gene cluster mce4 encodes for a cholesterol import system. Cholesterol is not required for infection of mice or for growth in macrophages, but it appears to be essential for persistence in the lungs (123) .
Extracellular bacteria also incorporate lipids, and specifically in the case of Mycoplasma spp., B. burgdorferi, and H. pylori, it is cholesterol that is prominently incorporated.
Sterol incorporation by Mycoplasma has been documented for a long time (124, 125) . Similar to Borrelia and Helicobacter, the Mycoplasma spp. are not intracellular organisms and can modify free cholesterol into a glycolipid, specifically a cholesteryl-glucoside (126, 127) . Mycoplasma can acquire cholesterol directly from serum lipoproteins (128) . The distribution of lipids in the membrane also appears to be in segregated domains, reminiscent of lipid rafts in Mycoplasma gallisepticum (129) . The uptake of cholesterol and phospholipids by several species of Mycoplasma is mediated by protein receptors, presumably for lipoproteins, and also by direct binding to membrane phospholipids and by existing glycolipids as well (130) . The lipids of Mycoplasma are involved in cell fusion. These organisms attach to eukaryotic cells through a filamentous tip with specific protein adhesins, known as the tip organelle. Two proteins, P1 and P30, are involved in adhesion, and their removal abolishes binding (131, 132) , and the consequences of adhesion in the pathogenesis of Mycoplasma infection are well known. In addition to this protein-mediated mechanism of adhesion, Mycoplasma can fuse with the target cells through an unesterified cholesterol-dependent process. Mycoplasma species adapted to grow without cholesterol supplements cannot fuse with cells (133) . Fusion of the Mycoplasma also appears to be influenced by choline glycolipids, but their roles are not well established (134) . The outcome of fusion may be to translocate effectors into the cell. The association of lipids with Mycoplasma spp. has been the topic of several excellent and comprehensive reviews beginning more than 50 years ago (135) (136) (137) .
USE OF HOST LIPIDS BY EXTRACELLULAR BACTERIA
Borrelia burgdorferi is an extracellular tick-borne bacterium that causes Lyme disease. The spirochete requires an external cholesterol source for growth and multiplication since it cannot synthesize cholesterol. Borrelia represents an interesting example among bacterial pathogens that incorporate host lipids, since so far, it has been the only prokaryote described to have cholesterol-rich microdomains ( Fig. 2) with all the hallmarks of eukaryotic lipid rafts (138) . The membrane of B. burgdorferi contains phosphatidylcholine, phosphatidylglycerol, and lipoproteins (139) (140) (141) . In addition, it has free cholesterol and two cholesterol glycolipids, acylated cholesteryl galactoside (ACGal) and cholesteryl galactoside (CGal), as well as a noncholesterol glycolipid, monogalactosyl diacylglycerol (MGalD) (142-145). Early studies established a link between the spirochete and host lipid by showing how B. burgdorferi elicits an antibody response in infected rats that targeted the host gangliosides (146) . The basis of this cross-reaction is likely the presence of cholesterol glycolipids, specifically the beta linkage between the galactose and the cholesterol group. The first evidence that B. burgdorferi has lipid raft microdomains in its membrane came from the study of the mechanism of the complement-independent antibody CB2. This antibody targets the outer surface lipoprotein OspB, and its bactericidal action was shown to be dependent on the presence of cholesterol glycolipids and cholesterol (147) . Further analysis of these cholesterol glycolipids showed that they had an uneven distribution on the membrane of the spirochete, forming clusters or microdomains (Fig. 2) . In addition, the number and size of these microdomains were shown to be temperaturedependent, and they were present in both culture-and mouse-derived spirochetes (147) . Subsequent studies using biochemical approaches showed that Borrelia microdomains have all the hallmarks of eukaryotic lipid rafts despite lacking sphingolipids (138) . In addition, cholesterol substitution experiments with live spirochetes using a range of sterols with different lipid raft formation properties showed that sterols that support raft formation were necessary and sufficient for the formation of B. burgdorferi membrane microdomains. Also, these sterols supported a higher number of detergent resistance membranes and were critical for membrane integrity (138) .
Traditionally, studies of lipid rafts have used membrane models, and in this sense experiments using live Borrelia represent an opportunity to study the properties and dynamics of lipid rafts in a live organism. The role of lipid rafts in Borrelia are not yet known, but there are selective proteins including proteins that are tightly regulated during infection (148) and that play important roles in the life cycle of the bacterium. Therefore, it is possible that B. burgdorferi lipid rafts share functional roles with eukaryotic lipid rafts. Although lipid rafts contain a subset of specific proteins, little is known about the contribution of proteins to the actual lipid raft structure. A recent study addressed the structural contribution of selective proteins to lipid rafts in B. burgdorferi, showing that raft-associated lipoproteins contribute to lipid raft formation, whereas nonassociated raft proteins do not (149) . B. burgdorferi needs to recruit cholesterol to form the glycolipids that are subsequently exported to the membrane, where they form lipid rafts. This bacterium establishes a cross-talk with the eukaryotic cell that results in the exchange of antigen and lipids. B. burgdorferi not only acquires cholesterol from epithelial cells by direct contact, but it also has the ability to recruit cholesterol from host-derived vesicles (150) . In both cases, the acquisition of cholesterol in B. burgdorferi is time dependent (150) , and it is glycosylated by undetermined bacterial enzymes (151) to make one of the most prominent glycolipids in the spirochete membrane, cholesteryl galactoside, which can be acylated to form acyl-cholesteryl galactoside. The mechanism by which B. burgdorferi acquires cholesterol from the host cell has not been defined yet, but it has been hypothesized that it could be through lipid raftlipid raft interactions between the spirochete and the host cell (150) .
Although H. pylori is not an intracellular organism, it is one of the growing number of bacteria that incorporate cholesterol. Cholesterol incorporation by this agent is followed by the conversion of free cholesterol into a glucosyl-cholesterol complex. Cholesteryl glucosides are infrequent in bacteria. Moreover, those in H. pylori have an α-glycosidic linkage, which is unusual for natural glycosides. Sugar incorporation is attained by a glucosylation of the free hydroxyl group of cholesterol. Three kinds of glycolipids have been identified to be cholesteryl glucosides. Two of them were determined to be cholesteryl-α-D-glucopyranoside and cholesteryl-6-Otetrade-canoyl-α-D-glucopyranoside, and the plausible structure of the third one was identified as cholesteryl-6-O-phosphatidyl-a-D-glucopyranoside. This last structure contains a phosphate-linked cholesteryl glycoside that is also unique to this organism. The affinity of H. pylori for cholesterol has been known for a long time (152) , and this affinity is specific because this organism does not bind other steroids, and other common bacterial pathogens do not bind cholesterol (153) . Furthermore, cholesterol supplementation is essential for the growth of H. pylori in culture, allowing it to avoid the use of serum (154) .
Cholesterol acquisition by Helicobacter spp. is not well understood. One phospholipid of H. pylori, phosphatidylethanolamine, can bind free cholesterol, cholesterol esters, and a methyl-β-cyclodextrin-free cholesterol complex. In contrast, E. coli (which is not known to incorporate cholesterol as used as a control) had significantly less affinity for free cholesterol than H. pylori. This study disclosed that the fatty acid composition of phosphatidylethanolamine of H. pylori was important in binding sterols (155) . Curiously, H. pylori senses cholesterol in the environment and displays a chemotactic response to areas of greater cholesterol concentrations. This organism can also acquire cholesterol directly from cell membranes, and does so by destroying the cell lipid rafts (156) .
As mentioned, H. pylori acquires cholesterol from its environment and glycosylates to form glucosylcholesterol. This complex is incorporated into the membrane by an α-glucosyltransferase (157) and has been shown to have important effects on the viability and integrity of this bacterium. In a study to determine the role of cholesterol in antibiotics and antimicrobial peptides, it was found that bacteria grown in the absence of cholesterol were significantly more susceptible to the action of these agents (158) . The glucosyl-cholesterol complex can be beneficial to H. pylori, because this bacterium can glucosylate toxic sterols and integrate the complex into the membrane without harming the organism. In contrast, mutants of the glucosyl transferase are killed by toxic sterols (159) . Cholesterol in H. pylori modifies the membranes so that colonization of the gastric mucosa and expression of Lewis antigen are not impaired (160) .
The cytotoxin-associated gene A (CagA) is the prominent virulence factor of H. pylori. It is translocated into cells by the T4SS encoded by the Cag pathogenicity island. Colonization of the gastric mucosa leads to chronic gastritis and development of disease that is dependent on the T4SS and the ability to incorporate cholesterol derived from the host. In addition, CagA is an indicator of gastric cancer risk because it interferes with numerous cell-signaling pathways (161) . Cholesteryl glucosides promote the formation of functional T4SS, and mutants of components of the pathogenicity island have impaired activities of their T4SS that can be restored by complementation. Glucosyl cholesterol synthesized by H. pylori collects around host-pathogen contact sites and promotes the formation of a functional T4SS and, therefore, H. pylori infection (162) .
Cholesterol incorporation by H. pylori also has important consequences for the innate and adaptive immune responses. Free cholesterol and glucosylated cholesterols in the β-linkage (provided exogenously) promote enhanced phagocytosis, whereas cholesteryl-α-glucosides, the natural form in this organism, protect it from ingestion by phagocytes. The presence of the glucosylating enzyme assists this bacterium in evading several arms of the immune system (156).
HOST LIPIDS AS A SOURCE OF ENERGY
As mentioned before, intracellular pathogens can use a variety of lipids for different purposes including surviving in the phagosome and multiplying, among other functions. In addition, there are bacterial pathogens that can also recruit and use host lipids as a carbon source and for energy. Moreover, they can hijack the host lipid metabolism to create suitable reservoirs that facilitate the persistence of the pathogen in the human host. Several intracellular pathogens are known to do this, most notably but not exclusively, members of the genera Mycobacterium, including the human pathogens M. tuberculosis and Mycobacterium leprae.
There has been evidence since the 1950s that M. tuberculosis uses host lipids as the primary carbon source in vivo (163) . There are other Mycobacterium species, as well as other bacteria including C. burnetii and Vibrio cholera that feed on host lipids, but classically, M. tuberculosis has been illustrated as the prototype organism to explain how pathogens exploit and utilize host lipid as a carbon and energy source. M. tuberculosis and other members of the genus are unique organisms regarding their lipid composition and metabolism. M. tuberculosis possesses a large variety of diverse lipids, including glycolipids, mycolic acids, and polyketides in the cell wall (164) , which are encoded in the genome along with genes for their biosynthesis, some of them shared with distantly related organisms including plants and animals as well as other bacteria (165) . Moreover, the genome of M. tuberculosis has an overrepresentation of genes related to fatty acid metabolism, with approximately 250 distinct enzymes (165) . The enzymes that direct the degraded fatty acid products to different pathways influence the phenotype of the bacterium in different mouse models (166) (167) (168) .
Cholesterol is another prominent host lipid recruited by M. tuberculosis and used as a carbon source. Indeed, M. tuberculosis encodes a cholesterol import system that allows the bacterium to recruit cholesterol and grow even if cholesterol is the only available source of carbon and energy (123) . Even though M. tuberculosis does not require cholesterol for infection of mice or to grow in resting macrophages, it is essential for persistence in chronically infected animals and activated macrophages (169) . However, in the context of lipids and carbon metabolism, the most striking characteristic of M. tuberculosis is its plasticity, because it can use multiple lipid energy sources available in the host. Rather than relying on a single source, this organism cocatabolizes multiple carbon sources (170) . The adaptability of the carbon metabolism pathways is key for the adaptation of this bacterium to the intracellular niche in the macrophage, and it has been associated with its pathogenicity (170) .
M. tuberculosis obtains fatty acids through the action of phospholipase C, an enzyme that hydrolyzes phospholipids, resulting in the release of fatty acids. The bacterium has four phospholipase C proteins encoded in four genes; three of them (plcA, plcB, and plcC) are in an operon, whereas plcD is located in a distant genomic region (165) . Phospholipase C proteins are associated with the cell wall through a lipid anchor and have been associated with the controlled degradation of phospholipids from the phagosomal membrane to obtain fatty acids that are subsequently used as a carbon and energy source. Phospholipases C are required for virulence (171) , and the polymorphisms of the enzymes have been associated with differential virulence in clinical isolates (172) . Although several proteins have been involved in the transport of fatty acids (173) and M. tuberculosis possesses homologs of Fad proteins (174) , the mechanisms by which the bacterium transports fatty acids to the cytoplasm are not well established. In addition, M. tuberculosis has an ABC transporter encoded in the mce4 operon that is dedicated to the transport of cholesterol and is essential for persistence in chronically infected animals and activated macrophages (123) . Interestingly, there are genes involved in lipid metabolism located near the mce4 operon that function in concert with the transporter (175) .
Mycobacterium spp. have adapted to feed on lipids. Cholesterol is an abundant compound in the membrane of eukaryotes, and it is metabolized by M. tuberculosis through a specific pathway that was identified by studying the catabolism of cholesterol in species of the related actinomycete Rhodococcus (176). All the genes need for the catabolism of cholesterol in Rhodococcus spp. were found in an 82-gene cluster in M. tuberculosis and Mycobacterium bovis (176). Despite the presence of these pathways, M. tuberculosis does not require cholesterol for infection in mice or to grow in resting macrophages; rather, it is essential for persistence in chronically infected animals and activated macrophages (169) . In addition, M. tuberculosis can grow even if cholesterol is the only source of carbon and energy available (123) .
Using cholesterol comes with a price for M. tuberculosis since the degradation of the cholesterol rings and acyl side chain by β-oxidation generates propionyl-CoA (177), a toxic compound that needs to be metabolized. However, M. tuberculosis has developed different strategies to metabolize propionyl-CoA that allow the bacterium not only to eliminate the toxic metabolite but also to use it as an energy source or as a building block for cell wall synthesis. To obtain energy from propionyl-CoA, M. tuberculosis can incorporate the metabolite into the methyl citrate cycle that converts propionyl-CoA into pyruvate and succinate, and these are subsequently used in the tricarboxylic acid cycle to produce energy (178) . This is possibly due to the methylisocitrate lyase enzymatic activity that isocitrate lyase enzymes have in M. tuberculosis. Also, to obtain energy, propionyl-CoA can be transformed into methylmalonyl-CoA, through the action of the propionyl-CoA carboxylase, and be incorporated into the vitamin B 12 -dependent methylmalonyl pathway that results in the production of succinyl-CoA that is used also in the tricarboxylic acid cycle (179) . Lastly, M. tuberculosis can use a third pathway to metabolize propionylCoA and utilize it as a building block for the cell wall (180). The bacterium achieves this through the action of a polyketide synthase that converts propionyl-CoA into methylmalonyl-CoA.
M. tuberculosis metabolizes fatty acids through two pathways: the β-oxidation cycle and the glyoxylate shunt. In the β-oxidation cycle, the fatty acids are broken down to produce acetyl-CoA. Although the β-oxidation cycle only requires five enzymes, M. tuberculosis has approximately 100 genes whose products are involved in the cycle and appear to have redundant enzymes for each reaction (181) . This redundancy has been associated with the ability of the bacterium to adapt to different environments during infection by switching its metabolism. The glyoxylate shunt is an anabolic pathway essential for carbon synthesis; it converts acetylCoA to succinate for the synthesis of carbohydrates, and it is widespread among prokaryotes.
To better understand the pathogenesis of M. tuberculosis, scientists have studied these pathways (Fig. 3) . The principal pathway for carbon synthesis is the glyoxylate shunt. However, since the β-oxidation pathway has an enzyme redundancy, the study of this pathway has proven to be cumbersome. Initial protein and genetic studies of Mycobacterium spp. showed that the glyoxylate shunt enzymes, isocitrate lyases (ICLs), were upregulated during infection in macrophages (182, 183) . M. tuberculosis has two isocitrate lyase homologous genes, icl1 and icl2, but only one, icl1, complements a Mycobacterium smegmatis icl mutant for growth on C 2 carbon sources (183) and therefore was the first to be characterized. The construction of an M. tuberculosis mutant that lacked icl1 showed that the mutation affects the survival of the bacterium in activated macrophages, while in mice, the icl1 mutation had a negative effect in the persistence of M. tuberculosis, but it did not affect growth during the acute phase of the infection (168) .
More recently, the role of icl2 in infection and growth was addressed using a genetic approach to generate single and double icl mutants, proving that ICL2 in conjunction with ICL1 is also important for growth and virulence. Mutations of both icl genes resulted in a severe survival defect in resting macrophages and complete clearance from activated macrophages. Also, double icl mutants were rapidly eliminated from the lungs of infected mice. Together, these results indicated that ICL1 and ICL2 are jointly required for both in vivo and in vitro growth and virulence and that the glyoxylate cycle is essential for M. tuberculosis (184) . However, the isocitrate lyase activity is not the only enzymatic activity that ICLs have involving fatty acid and cholesterol metabolism. ICLs also have a methylisocitrate lyase enzymatic activity, which is involved in the clearance of the propionyl-CoA, a product of the beta-oxidation of odd-chain fatty acids that is toxic for M. tuberculosis (185) . The biochemical mechanisms responsible for the dramatic phenotype observed in the icl mutants were unclear since ICLs were associated with both the ability to incorporate carbon from fatty acids through their ICL activity and the detoxification of propionyl-CoA metabolites through their MCL activity. A recent study shed some light using chemogenetic and metabolomics approaches and concluded that the methylcitrate cycle was responsible for the requirement of ICLs for the survival of M. tuberculosis (186) . In addition, this study established a connection between propionate metabolism and membrane bioenergetics (186) . ICLs have been associated with other functions that are not directly related to fatty acid metabolism, including antibiotic tolerance (187) and hypoxia (188) , but that will not be reviewed here.
Malate synthase (MS) is the second enzyme of the glyoxylate cycle and mediates the production of malate through the condensation of glyoxylate with an acetyl group. MS requires magnesium to function (189); indeed, a Mg 2+ -centered reaction mechanism in which glyoxylate binds first to enzymes has been proposed in M. tuberculosis (190) . In addition to its role in the glyoxylate cycle, MS may participate in the pathogenesis of M. tuberculosis since it has adapted to bind laminin and fibronectin (191) . Moreover, MS in M. tuberculosis is secreted by an undefined mechanism and enhances the adherence of the bacterium to lung epithelial cells in vitro (191) . Lastly, there is increasing interest in these enzymes due to the important roles that they have in the survival of M. tuberculosis during infection. Pharmacological inhibitors targeting both MS and ICLs to inhibit the ability of the bacterium to use host lipids and persist would be a fruitful avenue for therapy of tuberculosis (192) (193) (194) (195) .
During infection, M. tuberculosis as well as other organisms such as C. burnetii can alter the host lipid metabolism to create an environment that allows these FIGURE 3 Schematic representation of the tricarboxylic acid and methyl citrate cycles. In green, the glyoxylate shunt, a variation of the tricarboxylic acid cycle. intracellular pathogens to survive. Such alterations are examples of the manner whereby these pathogens hijack the metabolism of the host. For example, after the adaptive immune system develops, M. tuberculosis can survive and persist for decades in a dormant stage within a characteristic, and pathological, structure of mononuclear cells known as a granulomas. In approximately 10% of the cases, the infection will reactivate. Granulomas are basically a collection of immune cells, including different types of macrophages such as multinucleated giant cells, epithelioid cells, and foamy cells, surrounded by a rim of lymphocytes. One of the characteristics of the granuloma is the presence of the foamy cells. These are macrophages enriched with lipid droplets (196, 197) . The foamy macrophages are a secure reservoir for the bacterium and facilitate the persistence of M. tuberculosis in the host (196) . M. tuberculosis inside the foamy macrophages imports fatty acids derived from host triacylglycerol and uses it as a carbon and energy source during latency (198) . The mechanism by which M. tuberculosis manipulates the host cell metabolism is not completely understood. Nonetheless, several microbial compounds have been reported to induce differentiation of foamy macrophages.
During the infectious process, M. tuberculosis crosstalks with macrophages, reshaping host cell transcription (199) and reprogramming its lipid metabolism (200, 201) . A recent study showed that the bacterium diverts the glycolytic pathway cell toward ketone body synthesis in the foamy cells. This dysregulation enables feedback activation of the antilipolytic G protein-coupled receptor GPR109A, leading to perturbations in lipid homeostasis and consequent accumulation of lipid bodies in the macrophage (202) . Other mycobacterial molecules have been shown to be involved in the accumulation of lipid in foamy cells, including lipoarabinomannan, mycolic acids and ESAT-6, a secreted virulence factor (203) .
Recently, a new experimental model for foamy cells using M. avium and bone marrow-derived mouse macrophages was proposed. In this model, the infected macrophages are exposed to very-low-density lipoprotein as a lipid source. The results showed that macrophages acquired a foamy appearance and suggest that triacylglycerol is essential for the formation of intracytoplasmic lipid inclusions. In addition, the lipid transfer occurs by Mycobacterium-induced fusion of lipid bodies and phagosomes. Moreover, this process is reversible since upon removal of very-low-density lipoprotein, both lipid bodies and intracytoplasmic lipid inclusions decrease and M. avium starts to divide at the same levels as those found in the control macrophages (204) .
C. burnetii is also a good example of host metabolic reprograming. Cholesterol is an essential component of the parasitophorous vacuole. Also, Coxiella relies on host cholesterol for replication, and inhibition of the cholesterol uptake or biosynthesis results in the partial inhibition of the bacterium replication and alteration of the vacuolar morphology. Coxiella-infected cells have 75% more cholesterol, and this is coincident with the upregulation of host cell genes involved in cholesterol biosynthesis and exogenous cholesterol uptake (104) , suggesting that a cholesterol increase in the infected cell is required for optimal bacterial replication.
DISSEMINATION
Bacterial pathogens not only recruit and use host lipids during infection, but also target them through poreforming proteins and phospholipase enzymes that destabilize the vacuole and host cell membranes. These processes allow the intracellular pathogens to escape the phagosome and ultimately to escape the host cell and disseminate, which are essential processes for bacterial survival and proliferation. We will not review the extensive work on pore-forming proteins and phospholipases in this chapter because it would be off-topic, but we will summarize some findings that we feel are relevant.
Gram-positive bacteria including Streptococcus pneumoniae, Streptococcus pyogenes, L. monocytogenes, and many Clostridium species produce cholesterol-dependent cytolysins. The cholesterol-dependent cytolysins are a family of β-barrel toxins that require the presence of cholesterol for pore formation; members of this family include listeriolysin, streptolysin, pneumolysin, and perfringolysin. Listeriolysin O mediates the rupture of the phagosomal membrane, allowing L. monocytogenes to reach the cytosol, its niche, where its activity is tightly regulated to ensure the stability of the cell membrane (205) . Similarly, perfringolysin O allows Clostridium perfringens to escape the phagosome and persist in host tissues (206) . Streptolysin O serves two important functions in S. pyogenes: it mediates the formation of pores in the phagolysosomal membrane and translocate the toxin NAD-glycohydrolase to the cytosol (207). Lastly, pneumolysin, produced by S. pneumonia, has several functions including cytosolic lysis (208) , colonization (209) , and survival, by interfering with the host immune response (210) .
Bacterial phospholipases are enzymes that break down phospholipids, affecting the integrity of the membrane. Several bacteria species have enzymes with phos-pholipase activity. For example, C. perfringens has a phospholipase C that is involved in phagosomal escape. Phospholipases have also been associated with increased virulence; acquisition of bacteriophage encoding a phospholipase, SlaA, by a group A Streptococcus was shown to be associated with a dramatic increase of the virulence (211) . However, phospholipases can also affect the survival of the bacteria. This is the case for Legionella pneumophila phospholipase PlaA, whose activity ultimately kills the host cell and degrades the bacteria in the absence of SdhA (212) . Phospholipase activity is not an exclusive trait of intracellular pathogens; some extracellular pathogens also have it. For example, P. aeruginosa produces a phospholipase enzyme, ExoU, that enhance virulence and dissemination (213) . Importantly, a recent study showed that phospholipases are not only host-virulent factors, since they can serve as specific antibacterial effectors by degrading phosphatidylethanolamine (214) .
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